Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

100.91 +2.25 (+2.28%)
Official Closing Price Updated: 4:10 PM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,945,394
Open 100.21
Bid (Size) 100.25 (1)
Ask (Size) 101.77 (1)
Prev. Close 98.66
Today's Range 99.77 - 101.14
52wk Range 59.85 - 99.14
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 4 Health Care Stocks You May Want To Dump In Q1
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga

Performance

YTD
+12.90%
+12.90%
1 Month
+12.30%
+12.30%
3 Month
+14.61%
+14.61%
6 Month
+28.93%
+28.93%
1 Year
+66.13%
+66.13%

More News

Read More
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Via Investor's Business Daily
Stock Market Tumbles As Yields Spike; Nvidia, Tesla, Delta, Meta, Jobs Report In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why.
Via Chartmill
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product
Via Investor's Business Daily
Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal
Via Benzinga
Boston Scientific Surges Into Buy Zone On $900 Million Takeover Of Bolt Medical
Via Investor's Business Daily
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
Via Investor's Business Daily
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
NYSE:BSX may be ready to breakout.
Via Chartmill
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
Via Benzinga
Exposures Product Safety
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
Via AB Newswire
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
$100 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
“Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!”
Via AB Newswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.